AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,163 Cr | ₹1,809 Cr | ₹867 Cr | ₹903 Cr | ₹807 Cr |
What is the latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹1,163 Cr |
| Mar2024 | ₹1,809 Cr |
| Mar2023 | ₹867 Cr |
| Mar2022 | ₹903 Cr |
| Mar2021 | ₹807 Cr |
How is Total Non-Current Liabilities of AUROBINDO PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,163 Cr | -35.72 | |
| Mar2024 | ₹1,809 Cr | 108.67 | |
| Mar2023 | ₹867 Cr | -4.01 | |
| Mar2022 | ₹903 Cr | 11.87 | |
| Mar2021 | ₹807 Cr | - | |
Compare Total Non-Current Liabilities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹82,949.9 Cr | 0.5% | 6.4% | 13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,859.0 Cr | 4.2% | 5.3% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,618.0 Cr | 3.4% | 12.6% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,718.0 Cr | 2.2% | 4.1% | 28% | Stock Analytics | |
| CIPLA | ₹107,722.0 Cr | 2% | 11.5% | -13.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,081.0 Cr | -6.2% | 5.1% | 9.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 0.5% |
6.4% |
13.7% |
| SENSEX | -0.4% |
7.1% |
-4% |
You may also like the below Video Courses